CORRECTED-FDA approves Bristol-Myers' drug for rare fat disorder
(Corrects source to U.S. Food and Drug Administration from Bristol-Myers Squibb)
Feb 25 (Reuters) - The U.S. Food and Drug Administration said it approved Bristol-Myers Squibb Co's drug to treat rare and potentially fatal disorders involving loss of body fat.
The condition, known as generalized lipodystrophy, involves fat buildup in the blood and organs such as liver and muscle and can lead to diabetes, pancreatitis and fatty liver disease.
- Search planes find no sign of missing airliner at spot located by China |
- Missing jet may have strayed to west, Malaysia military says |
- Malaysia failing credibility test as flight confusion deepens
- White House tried to mediate dispute between Senate, CIA panel: source
- Vietnam search fruitless at site where China satellite detected suspected plane debris - witness